Abstract
Stem cell transplantation is currently generating a significant interest for use in the future treatment of cardiovascular diseases. Stem cell populations are rapidly increasing, and we are still in the search of optimal cell types to use in clinical trials as bone marrow stem cells did not show significant improvement in cardiac function following transplantation. Experimental stem cell studies raised the question on the true differentiation of tissue-specific cell types following transplantation. In fact, recent studies suggest that improved cardiac function is associated with inhibition of apoptosis and fibrosis provided by factors released from stem cells following transplantation. In this review, we will discuss the effects of transplanted stem cells on engraftment and differentiation as well as factors released from stem cells on apoptosis and cardiac remodeling.
Similar content being viewed by others
References
Anversa, P., Kajstura, J., & Olivetti, G. (1996). Myocyte death in heart failure. Current Opinion in Cardiology, 11, 245–251.
Behfar, A., Perez-Terzic, C., Faustino, R. S., Arrell, D. K., Hodgson, D. M., Yamada, S., et al. (2007). Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. Journal of Experimental Medicine, 204, 405–420.
Behfar, A., Zingman, L. V., Hodgson, D. M., Rauzier, J. M., Kane, G. C., Terzic, A., et al. (2002). Stem cell differentiation requires a paracrine pathway in the heart. FASEB Journal, 16, 1558–1566.
Dai, W., Hale, S. L., & Kloner, R. A. (2007). Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats 1. Regeneración Médica, 2, 63–68.
Emgard, M., Hallin, U., Karlsson, J., Bahr, B. A., Brundin, P., & Blomgren, K. (2003). Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue: A role for protease activation. Journal of Neurochemistry, 86, 1223–1232.
Gnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., Mu, H., et al. (2005). Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nature Medicine, 11, 367–368.
Gnecchi, M., He, H., Noiseux, N., Liang, O. D., Zhang, L., Morello, F., et al. (2006). Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB Journal, 20, 661–669.
Haider, H. K., & Ashraf, M. (2005). Bone marrow cell transplantation in clinical perspective. Journal of Molecular and Cellular Cardiology, 38, 225–235.
Haider, H. K., & Ashraf, M. (2005). Bone marrow stem cell transplantation for cardiac repair. American Journal of Physiology. Heart and Circulatory Physiology, 288, H2557–H2567.
Hayashi, M., Li, T. S., Ito, H., Mikamo, A., & Hamano, K. (2004). Comparison of intramyocardial and intravenous routes of delivering bone marrow cells for the treatment of ischemic heart disease: An experimental study. Cell Transplantation, 13, 639–647.
Hodgson, D. M., Behfar, A., Zingman, L. V., Kane, G. C., Perez-Terzic, C., Alekseev, A. E., et al. (2004). Stable benefit of embryonic stem cell therapy in myocardial infarction. American Journal of Physiology. Heart and Circulatory Physiology, 287, H471–H479.
Jugdutt, B. I. (2003). Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways. Current Drug Targets. Cardiovascular & Haematological Disorders, 3, 1–30.
Jugdutt, B. I. (2003). Ventricular remodeling after infarction and the extracellular collagen matrix: When is enough enough? Circulation, 108, 1395–1403.
Kofidis, T., de Bruin, J. L., Yamane, T., Balsam, L. B., Lebl, D. R., Swijnenburg, R. J., et al. (2004). Insulin-like growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration. Stem Cells, 22, 1239–1245.
Kofidis, T., de Bruin, J. L., Yamane, T., Tanaka, M., Lebl, D. R., Swijnenburg, R. J., et al. (2005). Stimulation of paracrine pathways with growth factors enhances embryonic stem cell engraftment and host-specific differentiation in the heart after ischemic myocardial injury. Circulation, 111, 2486–2493.
Kucia, M., Dawn, B., Hunt, G., Guo, Y., Wysoczynski, M., Majka, M., et al. (2004). Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction 12. Circulation Research, 95, 1191–1199.
Kumar, D., & Jugdutt, B. I. (2003). Apoptosis and oxidants in the heart. Journal of Laboratory and Clinical Medicine, 142, 288–297.
Kumar, D., Kamp, T. J., & LeWinter, M. M. (2005). Embryonic stem cells: Differentiation into cardiomyocytes and potential for heart repair and regeneration. Coronary Artery Disease, 16, 111–116.
Kumar, D., Lou, H., & Singal, P. K. (2002). Oxidative stress and apoptosis in heart dysfunction. Herz, 27, 662–668.
Laumonier, T., Yang, S., Konig, S., Chauveau, C., Anegon, I., Hoffmeyer, P., et al. (2008). Lentivirus mediated HO-1 gene transfer enhances myogenic precursor cell survival after autologous transplantation in pig. Molecular Therapy, 16, 404–410.
Li, W., Ma, N., Ong, L. L., Nesselmann, C., Klopsch, C., Ladilov, Y., et al. (2007). Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells, 25, 2118–2127.
Lunde, K., Solheim, S., Aakhus, S., Arnesen, H., Abdelnoor, M., Egeland, T., et al. (2006). Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. New England Journal of Medicine, 355, 1199–1209.
Menard, C., Hagege, A. A., Agbulut, O., Barro, M., Morichetti, M. C., Brasselet, C., et al. (2005). Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: A preclinical study. Lancet, 366, 1005–1012.
Meyer, G. P., Wollert, K. C., Lotz, J., Steffens, J., Lippolt, P., Fichtner, S., et al. (2006). Intracoronary bone marrow cell transfer after myocardial infarction: Eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation, 113, 1287–1294.
Min, J. Y., Chen, Y., Malek, S., Meissner, A., Xiang, M., Ke, Q., et al. (2005). Stem cell therapy in the aging hearts of Fisher 344 rats: Synergistic effects on myogenesis and angiogenesis. Journal of Thoracic and Cardiovascular Surgery, 130, 547–553.
Min, J. Y., Yang, Y., Converso, K. L., Liu, L., Huang, Q., Morgan, J. P., et al. (2002). Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. Journal of Applied Physiology, 92, 288–296.
Moriya, K., Yoshikawa, M., Saito, K., Ouji, Y., Nishiofuku, M., Hayashi, N., et al. (2007). Embryonic stem cells develop into hepatocytes after intrasplenic transplantation in CCl4-treated mice. World Journal of Gastroenterology, 13, 866–873.
Muller-Ehmsen, J., Whittaker, P., Kloner, R. A., Dow, J. S., Sakoda, T., Long, T. I., et al. (2002). Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. Journal of Molecular and Cellular Cardiology, 34, 107–116.
Nelson, T. J., Martinez-Fernandez, A., Yamada, S., Perez-Terzic, C., Ikeda, Y., & Terzic, A. (2009). Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation, 120, 408–416.
Nelson, T. J., Martinez-Fernandez, A., Yamada, S., Perez-Terzic, C., Ikeda, Y., & Terzic, A. (2009). Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells 4. Circulation, 120, 408–416.
Nussbaum, J., Minami, E., Laflamme, M. A., Virag, J. A., Ware, C. B., Masino, A., et al. (2007). Transplantation of undifferentiated murine embryonic stem cells in the heart: Teratoma formation and immune response. FASEB Journal, 21, 1345–1357.
Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., et al. (2001). Bone marrow cells regenerate infarcted myocardium. Nature, 410, 701–705.
Reubinoff, B. E., Pera, M. F., Fong, C. Y., Trounson, A., & Bongso, A. (2000). Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nature Biotechnology, 18, 399–404.
Schachinger, V., Assmus, B., Britten, M. B., Honold, J., Lehmann, R., Teupe, C., et al. (2004). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: Final one-year results of the TOPCARE-AMI Trial. Journal of the American College of Cardiology, 44, 1690–1699.
Schachinger, V., Erbs, S., Elsasser, A., Haberbosch, W., Hambrecht, R., Holschermann, H., et al. (2006). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. New England Journal of Medicine, 355, 1210–1221.
Singla, D. K. (2009). Embryonic stem cells in cardiac repair and regeneration. Antioxidants and Redox Signaling, 11(8), 1857–1863.
Singla, D. K., Hacker, T. A., Ma, L., Douglas, P. S., Sullivan, R., Lyons, G. E., et al. (2006). Transplantation of embryonic stem cells into the infarcted mouse heart: Formation of multiple cell types. Journal of Molecular and Cellular Cardiology, 40, 195–200.
Singla, D. K., Lyons, G. E., & Kamp, T. J. (2007). Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. American Journal of Physiology. Heart and Circulatory Physiology, 293, H1308–H1314.
Singla, D. K., & McDonald, D. E. (2007). Factors released from embryonic stem cells inhibit apoptosis of H9c2 cells. American Journal of Physiology. Heart and Circulatory Physiology, 293, H1590–H1595.
Singla, D. K., Singla, R. D., & McDonald, D. E. (2008). Factors released from embryonic stem cells inhibit apoptosis in H9c2 cells through P1–3kinase/Akt but not ERK pathway. American Journal of Physiology Heart and Circulatory Physiology, 294(2), H907–H913.
Suzuki, K., Murtuza, B., Beauchamp, J. R., Brand, N. J., Barton, P. J., Varela-Carver, A., et al. (2004). Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart. Circulation, 110, II219–II224.
Suzuki, K., Smolenski, R. T., Jayakumar, J., Murtuza, B., Brand, N. J., & Yacoub, M. H. (2000). Heat shock treatment enhances graft cell survival in skeletal myoblast transplantation to the heart. Circulation, 102, III216–III221.
Tendera, M., Wojakowski, W., Ruzyllo, W., Chojnowska, L., Kepka, C., Tracz, W., et al. (2009). Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: Results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial 1. European Heart Journal, 30, 1313–1321.
Togel, F., Hu, Z., Weiss, K., Isaac, J., Lange, C., & Westenfelder, C. (2005). Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms 9. American Journal of Physiology. Renal, Physiology, 289, F31–F42.
Wang, Y., Ahmad, N., Wani, M. A., & Ashraf, M. (2004). Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis 1. Journal of Molecular and Cellular Cardiology, 37, 1041–1052.
Wojakowski, W., Tendera, M., Michalowska, A., Majka, M., Kucia, M., Maslankiewicz, K., et al. (2004). Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction 1. Circulation, 110, 3213–3220.
Xu, M., Uemura, R., Dai, Y., Wang, Y., Pasha, Z., & Ashraf, M. (2007). In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. Journal of Molecular and Cellular Cardiology, 42, 441–448.
Xu, M., Uemura, R., Dai, Y., Wang, Y., Pasha, Z., & Ashraf, M. (2007). In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function 1. Journal of Molecular and Cellular Cardiology, 42, 441–448.
Yamada, S., Nelson, T. J., Behfar, A., Crespo-Diaz, R. J., Fraidenraich, D., & Terzic, A. (2009). Stem cell transplant into preimplantation embryo yields myocardial infarction-resistant adult phenotype. Stem Cells, 27, 1697–1705.
Yamada, S., Nelson, T. J., Behfar, A., Crespo-Diaz, R. J., Fraidenraich, D., & Terzic, A. (2009). Stem cell transplant into preimplantation embryo yields myocardial infarction-resistant adult phenotype 5. Stem Cells, 27, 1697–1705.
Zhang, Z., Deb, A., Zhang, Z., Pachori, A., He, W., Guo, J., et al. (2009). Secreted frizzled related protein 2 protects cells from apoptosis by blocking the effect of canonical Wnt3a 1. J Mol Cell Cardiol, 46, 370–377.
Zhang, M., Methot, D., Poppa, V., Fujio, Y., Walsh, K., & Murry, C. E. (2001). Cardiomyocyte grafting for cardiac repair: Graft cell death and anti-death strategies. Journal of Molecular and Cellular Cardiology, 33, 907–921.
Acknowledgment
We acknowledge the support provided by 1R21 HL085795-01A1 and 1R01HL090646-01 (to DKS).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Singla, D.K. Stem Cells in the Infarcted Heart. J. of Cardiovasc. Trans. Res. 3, 73–78 (2010). https://doi.org/10.1007/s12265-009-9151-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-009-9151-4